Teva, Trump Administration Announce Intent To Reach Agreement On Affordable Medicines
TEVA•Teva says it is in talks with Trump administration on drug pricing and supply chain security
Aug. 31 (Reuters) - Teva Pharmaceutical Industries Limited TEVA.TA:
- Teva and the Trump administration announce intent to reach agreement around affordable medicines and supply chain security for patients in the U.S.
- Teva says it remains in active discussions with the Trump administration to strike a deal anchored in all four of the president's drug pricing priorities.
- Teva says the conditions of negotiation to reach a final agreement remain confidential.
- Teva says it has offered a dedicated reserve of certain active pharmaceutical ingredients for public health needs.
- Teva says it has offered continued investment into U.S. pharmaceutical manufacturing capabilities.
Source text: ID:nGNX55hGqM
Further company coverage: TEVA.TA
